Correction: Concentrations and properties of ice nucleating substances in exudates from Antarctic sea-ice diatoms.

Correction for 'Concentrations and properties of ice nucleating substances in exudates from Antarctic sea-ice diatoms' by Yu Xi et al., Environ. Sci.: Processes Impacts, 2021, 23, 323-334, DOI: 10.1039/D0EM00398K.

Proton therapy for craniopharyngioma in adults: a protocol for systematic review and meta-analysis.

INTRODUCTION: Craniopharyngioma is the most challenging to treat brain tumour with high recurrence rates, which can be effectively reduced by adjuvant radiotherapy. In recent years, proton therapy (PT), with its physical properties of heavy ion beam, that is, Prague peak phenomenon, has been more frequently used in patients with craniopharyngioma. Compared with conventional X-ray beam radiotherapy, PT can reduce the damage to normal tissues and enlarge the damage to tumours. Some studies have shown that PT has advantages in the treatment of craniopharyngioma in adults. However, the optimal management of craniopharyngioma remains controversial. The purpose of this study was to evaluate the efficacy and safety of PT for craniopharyngioma in adults. METHODS AND ANALYSIS: We will search six databases (MEDLINE, EMBASE, Web of Science, the Cochrane Library, Amed, Scopus), clinical research registration websites and grey literature, aiming to identify randomised controlled trials (RCTs) on PT for craniopharyngioma in adults between 1 January 1954 and 28 September 2021. In the RCTs, PT will be used as the intervention group, and conventional X-ray beam radiotherapy will be used as the comparator group. Tumour recurrence and survival will be the primary outcome, and treatment-related toxicity will be the secondary outcome. The study selection, data extraction, bias risk and quality evaluation will be operated by two to four researchers independently. We will use Review Manager V.5.2 (RevMan V.5.2) for data analysis. If there is significant heterogeneity, we will identify the source of heterogeneity by subgroup analysis. ETHICS AND DISSEMINATION: Our study is based on existing RCTs and does not require ethical approval. The results of the study will be published in a peer-reviewed journal or at a related conference. PROSPERO REGISTRATION NUMBER: CRD42020200909.

Concentrations and properties of ice nucleating substances in exudates from Antarctic sea-ice diatoms.

The ocean contains ice nucleating substances (INSs), some of which can be emitted to the atmosphere where they can influence the formation and properties of clouds. A possible source of INSs in the ocean is exudates from sea-ice diatoms. Here we examine the concentrations and properties of INSs in supernatant samples from dense sea-ice diatom communities collected from Ross Sea and McMurdo Sound in the Antarctic. The median freezing temperatures of the samples ranged from approximately -17 to -22 °C. Based on our results and a comparison with results reported in the literature, the ice nucleating ability of exudates from sea-ice diatoms is likely not drastically different from the ice nucleating ability of exudates from temperate diatoms. The number of INSs per mass of DOC for the supernatant samples were lower than those reported previously for the sea surface microlayer and bulk sea water collected in the Arctic and Atlantic. The INSs in the supernatant sample collected from Ross Sea were not sensitive to temperatures up to 100 °C, were larger than 300 kDa, and were different from ice shaping and recrystallization inhibiting molecules present in the same sample. Possible candidates for these INSs include polysaccharide containing nanogels. The INSs in the supernatant sample collected from McMurdo Sound were sensitive to temperatures of 80 and 100 °C and were larger than 1000 kDa. Possible candidates for these INSs include protein containing nanogels.

The safety and efficacy of endoscopic endonasal approach in the treatment of recurrent craniopharyngioma: A protocol for systematic review and meta-analysis.

BACKGROUND: Craniopharyngioma is the most challenging brain tumor with a high recurrence rate. Some scholars have shown that endoscopic endonasal approach (EEA) can achieve a higher total tumor resection rate and significantly reduce the incidence of complications and mortality. However, there is still no consensus on the surgical approach for recurrent craniopharyngioma. The purpose of this study is to evaluate the safety and efficacy of EEA in the treatment of recurrent craniopharyngioma. METHODS: We will search 7 electronic databases (PubMed, EMBASE, Web of Science, the Cochrane Library, PsycINFO, AMED, Scopus) to collect related randomized controlled trials (RCTs). The resection rate, recurrence rate and progression-free survival rate will be regarded as the primary outcome, and the incidence of complications will be regarded as the secondary outcome. Endnote Software X9.0 will be used to filter articles, Review Manager Software 5.2 and STATA software 16.0 will be used for analysis and synthesis. RESULTS: We will integrate existing studies to assess the safety and efficacy of EEA in the treatment of recurrent craniopharyngioma. CONCLUSION: Our study will provide EEA as an effective and safe treatment for recurrent craniopharyngioma. REGISTRATION NUMBER: International Prospective Register of Systematic Reviews (PROSPERO): CRD42020199860.